Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2020 | 2 |
2021 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Translational Nanomedicine Boosts Anti-PD1 Therapy to Eradicate Orthotopic PTEN-Negative Glioblastoma.
ACS Nano. 2020 Aug 25;14(8):10127-10140. doi: 10.1021/acsnano.0c03386. Epub 2020 Aug 6.
ACS Nano. 2020.
PMID: 32806051
Nanomedicines blocking adaptive signals in cancer cells overcome tumor TKI resistance.
Kinoh H, Shibasaki H, Liu X, Yamasoba T, Cabral H, Kataoka K.
Kinoh H, et al. Among authors: shibasaki h.
J Control Release. 2020 May 10;321:132-144. doi: 10.1016/j.jconrel.2020.02.008. Epub 2020 Feb 4.
J Control Release. 2020.
PMID: 32032656
Item in Clipboard
Efficacy of pH-Sensitive Nanomedicines in Tumors with Different c-MYC Expression Depends on the Intratumoral Activation Profile.
Shibasaki H, Kinoh H, Cabral H, Quader S, Mochida Y, Liu X, Toh K, Miyano K, Matsumoto Y, Yamasoba T, Kataoka K.
Shibasaki H, et al.
ACS Nano. 2021 Mar 23;15(3):5545-5559. doi: 10.1021/acsnano.1c00364. Epub 2021 Feb 24.
ACS Nano. 2021.
PMID: 33625824
Item in Clipboard
Cite
Cite